Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF
Abstract Multiple molecular subtypes and distinct clinical outcomes in breast cancer, necessitate specific therapy. Moreover, despite the improvements in breast cancer therapy, it remains the fifth cause of cancer-related deaths, indicating the involvement of unknown genes. To identify novel contrib...
Autors principals: | , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Nature Publishing Group
2022-11-01
|
Col·lecció: | Cell Death Discovery |
Accés en línia: | https://doi.org/10.1038/s41420-022-01240-w |